Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-08 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-06 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-05 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |